Indofarma Tbk Valuation
| INAF Stock | IDR 126.00 0.00 0.00% |
At this time, the firm appears to be fairly valued. Indofarma Tbk retains a regular Real Value of 126.0 per share. The prevalent price of the firm is 126.0. Our model calculates the value of Indofarma Tbk from evaluating the firm fundamentals such as Return On Equity of -0.59, return on asset of -0.0451, and Current Valuation of 3.17 T as well as inspecting its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Indofarma Tbk's price fluctuation is very steady at this time. Calculation of the real value of Indofarma Tbk is based on 3 months time horizon. Increasing Indofarma Tbk's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Indofarma Tbk's intrinsic value may or may not be the same as its current market price of 126.00, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 126.0 | Real 126.0 | Hype 126.0 | Naive 126.0 |
The intrinsic value of Indofarma Tbk's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Indofarma Tbk's stock price.
Estimating the potential upside or downside of Indofarma Tbk helps investors to forecast how Indofarma stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Indofarma Tbk more accurately as focusing exclusively on Indofarma Tbk's fundamentals will not take into account other important factors: Indofarma Tbk Total Value Analysis
Indofarma Tbk is currently forecasted to have takeover price of 3.17 T with market capitalization of 2.59 T, debt of 397.52 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Indofarma Tbk fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.17 T | 2.59 T | 397.52 B |
Indofarma Tbk Investor Information
About 88.0% of the company shares are held by company insiders. The company recorded a loss per share of 29.18. Indofarma Tbk last dividend was issued on the 3rd of May 2013. Indofarma Tbk is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Indofarma Tbk Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Indofarma Tbk has an asset utilization ratio of 144.24 percent. This suggests that the Company is making 1.44 for each dollar of assets. An increasing asset utilization means that Indofarma Tbk is more efficient with each dollar of assets it utilizes for everyday operations.Indofarma Tbk Ownership Allocation
Indofarma Tbk secures a total of 3.1 Billion outstanding shares. Indofarma Tbk retains majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 88.0 (percent) of Indofarma Tbk outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.Indofarma Tbk Profitability Analysis
The company reported the revenue of 2.9 T. Net Loss for the year was (37.58 B) with profit before overhead, payroll, taxes, and interest of 442.87 B.About Indofarma Tbk Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Indofarma Tbk. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Indofarma Tbk based exclusively on its fundamental and basic technical indicators. By analyzing Indofarma Tbk's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Indofarma Tbk's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Indofarma Tbk. We calculate exposure to Indofarma Tbk's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Indofarma Tbk's related companies.8 Steps to conduct Indofarma Tbk's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Indofarma Tbk's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Indofarma Tbk's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Indofarma Tbk's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Indofarma Tbk's revenue streams: Identify Indofarma Tbk's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Indofarma Tbk's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Indofarma Tbk's growth potential: Evaluate Indofarma Tbk's management, business model, and growth potential.
- Determine Indofarma Tbk's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Indofarma Tbk's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Other Information on Investing in Indofarma Stock
Indofarma Tbk financial ratios help investors to determine whether Indofarma Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Indofarma with respect to the benefits of owning Indofarma Tbk security.